Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Hong Kong SAR 1996-200156131054.660.725155.258.93293751687669.846.539.244.546.0
China - Qidong 1992-200081443.53.6378.69.3379141566.50.00.013.70.0
China - Shangai 1992-199533821031.034.012822.724.21732954602228.528.432.638.220.9
China - Tianjin 1991-199930918563.969.412458.160.91683344461862.862.866.574.091.1
India - Bhopal 1991-1995322714.815.5525231112.20.039.20.00.0
India - Chennai 1990-199943328223.123.915125.325.937982120527.50.07.20.00.0
India - Karunagappally 1991-1997382444.845.91421.421.833130136.60.00.00.00.0
India - Mumbai 1992-1994109972514.615.537416.417.78037093706317.614.310.413.112.2
Singapore 1993-199720512741.642.87850.051.0155111418751.637.123.533.50.0
Republic of Korea - Busan 1996-200122214237.437.78049.750.1183151410048.123.819.60.00.0
Republic of Korea - Incheon 1997-20011256249.349.76351.051.8100796357.80.047.10.00.0
Republic of Korea - Seoul 1993-199759534337.438.125247.948.4483343336946.118.125.239.214.2
Thailand - Chiang Mai 1993-1997704918.818.92123.823.955555025.20.00.00.015.4
Thailand - Lampang 1990-20001096837.538.44143.644.1786711742.150.644.147.50.0
Thailand - Songkhla 1990-1999995144.044.34852.753.486424351.872.60.00.00.0
Turkey - Izmir 1995-19971619345.849.66851.353.8962016191053.447.149.837.773.7



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period